Our image of the month shows Dr William Notcutt at our Wellcome Witness seminar ‘The Medicalization of Cannabis’. After qualifying from Birmingham University and working as a flying doctor in Lesotho, Dr Notcutt took up anaesthesia. His main interest is pain relief and he started a palliative care service in 1985, introduced patient-controlled analgesia for acute pain in 1986. He started working with the synthetic cannabinoid Nabilone for chronic pain in 1993, and organized the first clinical trials of the cannabinoid oromucosal mouth spray Sativex in 2000. He is chair of the ethics group of the British Pain Society (since 2005), and Honorary Senior Lecturer at Norwich Medical School.